Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 20;5(3):356-359.
doi: 10.1016/j.jaccao.2023.05.002. eCollection 2023 Jun.

Remote Ischemic Conditioning for Anthracycline Cardiotoxicity: The Need to Protect the Most Vulnerable

Borja Ibáñez  1   2   3 , Maria Gomes-Silva  4
Affiliations
Editorial

Remote Ischemic Conditioning for Anthracycline Cardiotoxicity: The Need to Protect the Most Vulnerable

Borja Ibáñez et al. JACC CardioOncol. .
No abstract available

Keywords: anthracyclines; cardiooncology; cardioprotection; cardiotoxicity; conditioning.

PubMed Disclaimer

Conflict of interest statement

Drs Ibáñez and Gomes-Silva are funded by the European Commission (H2020-HEALTH “RESILIENCE”, grant number 945118). Dr Ibáñez is recipient of an ERC-CoG (grant number 819775) and has received funds from the Spanish Ministry of Science and Innovation (PID2019-110369RB-I00), and from the Comunidad de Madrid (S2022/BMD-7403, RENIM-CM). The CNIC is supported by the ISCIII, the Ministry of Science and Innovation, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (CEX2020-001041-S). Dr. Gomes-Silva has received grants from Astrazeneca; has received advisory board payments from Janssen, Gilead Sciences, Merck Sharp and Dohme, Bristol Myers Squibb, Roche, Takeda, Novartis, and ADC Therapeutics; and has received travel support from Roche, Janssen, Abbvie, Gilead, Takeda (all unrelated to the content of this paper).

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

References

    1. Zaorsky N.G., Churilla T.M., Egleston B.L., et al. Causes of death among cancer patients. Ann Oncol. 2017;28:400–407. - PMC - PubMed
    1. Bhatia S. Genetics of anthracycline cardiomyopathy in cancer survivors: JACC: CardioOncology state-of-the-art review. J Am Coll Cardiol CardioOnc. 2020;2:539–552. - PMC - PubMed
    1. Brice P., de Kerviler E., Friedberg J.W. Classical Hodgkin lymphoma. Lancet. 2021;398:1518–1527. - PubMed
    1. Bataillard E.J., Cheah C.Y., Maurer M.J., Khurana A., Eyre T.A., El-Galaly T.C. Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review. Blood Adv. 2021;5:2426–2437. - PMC - PubMed
    1. Galan-Arriola C., Lobo M., Vilchez-Tschischke J.P., et al. Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity. J Am Coll Cardiol. 2019;73:779–791. - PubMed

LinkOut - more resources